HIGHLIGHTS
- who: Milos Holanek et al. from the Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty kopec, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk University, Kamenice, have published the research work: Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy, in the Journal: Diagnostics 2022, 1740 of 19/06/2022
- what: The aim of this retrospective study on a single-institution consecutive cohort of BC patients neoadjuvantly treated outside clinical trials was to evaluate biomarkers assessed from the residual cancer burden in patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.